Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 04, 2024, titled "Torrent Pharma enters into an agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands".
Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 04, 2024, titled "Torrent Pharma enters into an agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands".